These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23803722)

  • 21. What is the significance of a microscopically positive resection margin in the curative-intent treatment of rectal adenocarcinoma? A retrospective study.
    Fekete Z; Muntean A; Irimie A; Hica S; Resiga L; Todor N; Nagy V
    J BUON; 2013; 18(4):989-95. PubMed ID: 24344028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database.
    Al-Sukhni E; Attwood K; Gabriel E; Nurkin SJ
    Int J Surg; 2016 Apr; 28():112-7. PubMed ID: 26906328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Access to Hospitals Most Ready to Achieve National Accreditation for Rectal Cancer Treatment.
    Antunez AG; Kanters AE; Regenbogen SE
    JAMA Surg; 2019 Jun; 154(6):516-523. PubMed ID: 30785616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Care and Outcomes of Rectal Cancer Patients from the Iowa Cancer Registry: Role of Hospital Volume and Tumor Location.
    Goffredo P; Hart AA; Tran CG; Kahl AR; Gao X; Del Vecchio NJ; Charlton ME; Hassan I
    J Gastrointest Surg; 2023 Jun; 27(6):1228-1237. PubMed ID: 36949239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 26. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
    Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
    Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nationwide Heterogeneity in Hospital-Specific Probabilities of Rectal Cancer Understaging and Its Effects on Outcomes.
    Becerra AZ; Wexner SD; Dietz DW; Xu Z; Aquina CT; Justiniano CF; Swanger AA; Temple LK; Noyes K; Monson JR; Fleming FJ
    Ann Surg Oncol; 2018 Aug; 25(8):2332-2339. PubMed ID: 29850952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal resection following neoadjuvant therapy in a Midwest community hospital setting: The case for standardization over centralization as the means to optimize rectal cancer outcomes in the United States.
    Cirocco WC
    Am J Surg; 2019 Mar; 217(3):430-434. PubMed ID: 30236488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery.
    Birbeck KF; Macklin CP; Tiffin NJ; Parsons W; Dixon MF; Mapstone NP; Abbott CR; Scott N; Finan PJ; Johnston D; Quirke P
    Ann Surg; 2002 Apr; 235(4):449-57. PubMed ID: 11923599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the laparoscopy on circumferential resection margin positivity in patients with rectal cancer: long-term outcomes at a single high-volume institution.
    Dural AC; Keskin M; Balik E; Akici M; Kunduz E; Yamaner S; Asoglu O; Gulluoglu M; Bugra D
    Surg Laparosc Endosc Percutan Tech; 2015 Apr; 25(2):129-37. PubMed ID: 25159046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital and surgeon variation in positive circumferential resection margin among rectal cancer patients.
    Justiniano CF; Aquina CT; Fleming FJ; Xu Z; Boscoe FP; Schymura MJ; Temple LK; Becerra AZ
    Am J Surg; 2019 Nov; 218(5):881-886. PubMed ID: 30853095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant-intensified treatment for rectal cancer: time to change?
    Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
    World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action.
    Healy MA; Peacock O; Hu CY; Bednarski BK; Tillman MM; Messick C; Kaur H; Chang GJ
    Ann Surg; 2022 Dec; 276(6):1023-1028. PubMed ID: 33630474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicentre study of circumferential margin positivity and outcomes following abdominoperineal excision for rectal cancer.
    Kennelly RP; Rogers AC; Winter DC;
    Br J Surg; 2013 Jan; 100(1):160-6. PubMed ID: 23147085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting of Circumferential Resection Margin in Rectal Cancer Surgery.
    Manisundaram N; DiBrito SR; Hu CY; Kim Y; Wick E; Palis B; Peacock O; Chang GJ
    JAMA Surg; 2023 Nov; 158(11):1195-1202. PubMed ID: 37728906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An up-to-date predictive model for rectal cancer survivorship reflecting tumor biology and clinical factors.
    Jarrar A; Edalatpour A; Sebikali-Potts A; Vitello D; Valente M; Liska D; Kalady M; Delaney CP; Steele SR
    Am J Surg; 2020 Mar; 219(3):515-520. PubMed ID: 31703835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk factors of coloanal anastomotic stricture after laparoscopic intersphincteric resection for low rectal cancer].
    Zhang B; Zhuo GZ; Tian L; Zhao K; Zhao Y; Zhao YJ; Zhu J; Zhang T; Ding JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):755-761. PubMed ID: 31422614
    [No Abstract]   [Full Text] [Related]  

  • 39. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Margin Positivity in Resectable Esophageal Cancer: Are there Modifiable Risk Factors?
    Schlick CJR; Khorfan R; Odell DD; Merkow RP; Bentrem DJ
    Ann Surg Oncol; 2020 May; 27(5):1496-1507. PubMed ID: 31933223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.